STAND. COM. REP. NO.  1163-16

Honolulu, Hawaii

                , 2016

RE:   S.B. No. 2181

      S.D. 2

      H.D. 1

Honorable Joseph M. Souki

Speaker, House of Representatives

Twenty-Eighth State Legislature

Regular Session of 2016

State of Hawaii

Sir:

     Your Committee on Health, to which was referred S.B. No. 2181, S.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS,"

begs leave to report as follows:

The purpose of this measure is to allow for terminally ill patients to use potentially life-saving investigational drugs and biological products by allowing a manufacturer of an investigational drug or biological product to make the drug or product available to an eligible terminally ill patient.

The Hawaii Association for Justice testified in support of this measure.  The Department of the Attorney General and Hawaii Medical Service Association commented on this measure.

     Your Committee has amended this measure by changing its effective date to July 1, 2112, to facilitate further discussion.

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2181, S.D. 2, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2181, S.D. 2, H.D. 1, and be referred to your Committee on Judiciary.

Respectfully submitted on behalf of the members of the Committee on Health,

____________________________

DELLA AU BELATTI, Chair